ReviewDermatology and therapy2022

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management.

Amy C M Musiek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.